Evommune, Inc.

EVMNNYSEHealthcareBiotechnology

$5.17- (-)

As of Oct 16, 2026 close

Market cap: $214.28M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $5.64$33.20
Volume (live): -
Avg. volume (3M): 924.80K

Evommune, Inc. (EVMN) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Evommune, Inc. stock.

Analyst Consensus Rating

Investment consensus from 12 professional research analysts

Consensus Rating

Buy

Based on 12 unique analysts

(13 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$24.00

+364.22% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest EVMN Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 5, 2026	Mitchell Kapoor	HC Wainwright	Reiterates	Hold	-
Sep 18, 2026	Prakhar Agrawal	Cantor Fitzgerald	Maintains	Buy	-
Sep 9, 2026	Kaveri Pohlman	Clear Street	Maintains	Buy	$28.00 → $23.00 −5.00 (−17.9%)
Sep 9, 2026	Alex Thompson CFA	Stifel Nicolaus	Maintains	Buy	$30.00
Sep 9, 2026	Mitchell Kapoor	HC Wainwright	Reiterates	Hold	-
Sep 9, 2026	Matt Phipps	William Blair	Maintains	Hold	-
Sep 9, 2026	Thomas Smith	Leerink Partners	Reiterates	Buy	$28.00 → $22.00 −6.00 (−21.4%)
Sep 9, 2026	Kostas Biliouris	Oppenheimer	Reiterates	Buy	$26.00
Sep 9, 2026	Martin Auster	Raymond James	Maintains	Buy	$18.00
Sep 9, 2026	Serge Belanger	Needham	Maintains	Buy	$28.00
Sep 8, 2026	Brian Abrahams	RBC Capital	Maintains	Buy	$29.00 → $21.00 −8.00 (−27.6%)
Aug 10, 2026	Gavin Clark-Gartner	Evercore ISI Group	Maintains	Buy	$22.00
Aug 10, 2026	Judah Frommer	Morgan Stanley	Initiates Coverage	Buy	$26.00

Mitchell Kapoor

HC Wainwright

HoldReiterates

Oct 5

Prakhar Agrawal

Cantor Fitzgerald

BuyMaintains

Sep 18

Kaveri Pohlman

Clear Street

BuyMaintains

$28.00 → $23.00

Sep 9

Alex Thompson CFA

Stifel Nicolaus

BuyMaintains

$30.00

Sep 9

Mitchell Kapoor

HC Wainwright

HoldReiterates

Sep 9

Matt Phipps

William Blair

HoldMaintains

Sep 9

Thomas Smith

Leerink Partners

BuyReiterates

$28.00 → $22.00

Sep 9

Kostas Biliouris

Oppenheimer

BuyReiterates

$26.00

Sep 9

Martin Auster

Raymond James

BuyMaintains

$18.00

Sep 9

Serge Belanger

Needham

BuyMaintains

$28.00

Sep 9

Brian Abrahams

RBC Capital

BuyMaintains

$29.00 → $21.00

Sep 8

Gavin Clark-Gartner

Evercore ISI Group

BuyMaintains

$22.00

Aug 10

Judah Frommer

Morgan Stanley

BuyInitiates Coverage

$26.00

Aug 10

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 5, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for EVMN?

The analyst consensus rating for EVMN is Buy, based on the latest ratings from 12 analysts over the last 90 days.

What is the average price target for EVMN?

The average 12-month price target for EVMN is $24.00, representing an upside of 364.2% from the Oct 16, 2026 close of $5.17.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.